Pharsight® Reference Library
Books
Marier JF, Gallicano K. Pharmacokinetic and Pharmacodynamic Biomarker Correlations. In Bleavins MR (ed), Carini C (ed), Jurima-Romet M (ed), Rahbari R (ed). Biomarkers in Drug Development: A Handbook of Practice, Application, and Strategy. John Wiley & Sons. 2010. Chapter 21. ISBN: 978-0-470-16927-8.
Colucci P, Marier JF, Ducharme MP. Population Pharmacokinetic Approaches for Assessing Bioequivalence. In Kanfer I (ed), Shargel L (ed). Generic Drug Product Development – Bioequivalence Issues. Taylor & Francis. 2007. ISBN: 0849377846.
Ezzet F, Pinheiro JC. Linear, Generalized Linear, and Nonlinear Mixed Effect Models. In; Ette EI (ed), Williams PJ (ed). Pharmacometrics: The Science of Quantitative Pharmacology. John Wiley & Sons. 2007. pp. 103-136. ISBN: 978-0-471-67783-3.
Tranchand B, Bruno R, Freyer G. Design of Phase I Studies in Oncology. In Ette EI (ed), Williams PJ (ed). Pharmacometrics: The Science of Quantitative Pharmacology. John Wiley & Sons. 2007. pp. 781-802. ISBN: 978-0-471-67783-3.
Gabrielsson J, Weiner D. Pharmacokinetic and Pharmacodynamic Data Analysis, Concepts and Applications, 4th ed. Stockholm, Sweden: Swedish Pharmaceutical Press; 2007. ISBN 91 9765 100 1.
Kastrissios H, Girard P. Protocol deviations and execution models. In Kimko HC, Duffull SB. Simulation for Designing Clinical Trials: A Pharmacokinetic-Pharmacodynamic Modeling Perspective. Marcel Dekker Inc. New York, NY. 2002. pp 55 - 72. ISBN 0-824-708628.
Krause A, Millard S (Editors). Applied Statistics in the Pharmaceutical Industry with Case Studies Using S-Plus. Springer-Verlag, New York; 2001. ISBN 0-387-988149.